Login / Signup

Efficacy and safety of pantoprazole and itopride in patients with overlap of gastroesophageal reflux disease and dyspepsia: A prospective, open-label, single-arm pilot study.

Sundeep LakhtakiaAniruddha P SinghNeeraj SinglaSana F MemonDuvvur N Reddy
Published in: JGH open : an open access journal of gastroenterology and hepatology (2024)
The FDC of pantoprazole and itopride showed favorable efficacy and safety in patients with GERD and overlapping dyspepsia refractory to pantoprazole monotherapy. Nevertheless, further studies are warranted.
Keyphrases
  • gastroesophageal reflux disease
  • open label
  • clinical trial
  • phase ii
  • phase iii
  • phase ii study
  • study protocol
  • combination therapy
  • radiation therapy
  • helicobacter pylori